Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 4 publications
Oral insulin (ORMD-0801) in type 2 diabetes mellitus: A dose-finding 12-week randomized placebo-controlled study.
Journal: Diabetes, obesity & metabolism
Published: February 09, 2022
Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients.
Journal: The New England journal of medicine
Published: August 28, 2018
Effect of lorcaserin on prevention and remission of type 2 diabetes in overweight and obese patients (CAMELLIA-TIMI 61): a randomised, placebo-controlled trial.
Journal: Lancet (London, England)
Published: August 22, 2018
Design and rationale for the Cardiovascular and Metabolic Effects of Lorcaserin in Overweight and Obese Patients-Thrombolysis in Myocardial Infarction 61 (CAMELLIA-TIMI 61) trial.
Journal: American heart journal
Published: July 18, 2017
Showing 1-4 of 4
Last Updated: 09/26/2026